Compound Evidence File
#EC-2026-0664
Test Base (No Ester)
Filed under Injectable Oils. The bureau holds 75 laboratory returns for this compound from 32 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
32 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 9.7 | 9.7 | 9.7 | 8 Jul 2025 | 8 Jul 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 8.7 | 8.3 | 9.3 | 24 May 2026 | 24 May 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | X | 1 | 8.7 | 8.7 | 8.7 | 14 Jan 2025 | 14 Jan 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.6 | 8.1 | 9.1 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.5 | 8.1 | 9.2 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.5 | 7.5 | 9.3 | 23 May 2026 | 23 May 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 8.4 | 8.4 | 8.4 | 13 Feb 2025 | 13 Feb 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 8.2 | 8.2 | 8.2 | 28 Mar 2025 | 28 Mar 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.0 | 7.1 | 9.0 | 23 May 2026 | 23 May 2026 |
| Skye PeptidesCASE #VI-2026-0451 | X | 3 | 7.9 | 6.9 | 8.7 | 6 May 2025 | 24 May 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 7.8 | 7.8 | 7.8 | 11 Jun 2025 | 11 Jun 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 7.8 | 7.8 | 7.8 | 27 Feb 2025 | 27 Feb 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 7.7 | 7.4 | 8.0 | 13 Jun 2025 | 24 May 2026 |
| Peptide SciencesCASE #VI-2026-0867 | X | 3 | 7.6 | 6.4 | 8.5 | 20 Jun 2025 | 21 May 2026 |
| Peptide-SCASE #VI-2026-0111 | X | 9 | 7.1 | 6.0 | 7.8 | 8 Jul 2025 | 20 May 2026 |
| Pure RawzCASE #VI-2026-0767 | X | 2 | 7.0 | 6.9 | 7.1 | 9 Jun 2025 | 21 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 6.7 | 6.7 | 6.7 | 28 Mar 2025 | 28 Mar 2025 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 6.5 | 6.5 | 6.5 | 7 May 2025 | 7 May 2025 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 6.3 | 6.3 | 6.3 | 2 Apr 2025 | 2 Apr 2025 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 5.7 | 5.7 | 5.7 | 3 Jun 2025 | 3 Jun 2025 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 | 24 Apr 2025 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 1 | 4.9 | 4.9 | 4.9 | 6 May 2025 | 6 May 2025 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 4.8 | 4.8 | 4.8 | 20 Jun 2025 | 20 Jun 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 2 | 4.5 | 3.7 | 5.3 | 16 Mar 2025 | 23 May 2026 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 4.4 | 4.4 | 4.4 | 17 Dec 2024 | 17 Dec 2024 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 4.1 | 4.1 | 4.1 | 13 Feb 2025 | 13 Feb 2025 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 3.7 | 3.7 | 3.7 | 6 May 2025 | 6 May 2025 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Jun 2025 | 13 Jun 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 0.0 | 0.0 | 0.0 | 11 Jun 2025 | 11 Jun 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 9 Jun 2025 | 9 Jun 2025 |
Open any subject to view the batch-level evidence for Test Base (No Ester) alone.